
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Anaphylaxis historical perspective
Introduction
Overview
Overview
The term comes from the Greek words ana (against) and phylaxis (protection).
Discovery
Anaphylaxis was first discovered by Charles Richet and Paul Portier, who were French physiologists in 1913. [1] During their study of Physalia, Portugese man- o -war toxin, they began a series of experiments on a dog. They injected the toxin in the dog and repeated this days later. [2] They found an exaggerated immune response resulting in the dog experiencing collapse of the airway, breathing, and circulatory systems. [1] They named it anaphylaxis as they felt the phenomenon was the opposite of protection, or prophylaxis. [3] Richet was awarded a Noble Prize for his work in 1913. [4]
Landmark Events in the Development of Treatment Strategies
In the year 1937, Daniel Bovet discovered antihistamines, and cortisone was introduced in the year 1949. [5]
References
References
- β 1.0 1.1 Ring J, Behrendt H, de Weck A (2010). “History and classification of anaphylaxis”. Chem Immunol Allergy. 95: 1β11. doi:10.1159/000315934. PMIDΒ 20519878.
- β Tan SY, Yamanuha J (2010). “Charles Robert Richet (1850-1935): discoverer of anaphylaxis”. Singapore Med J. 51 (3): 184β5. PMIDΒ 20428737.
- β Richet G (2003). “[The discovery of anaphylaxis, a brief but triumphant encounter of two physiologists (1902)]”. Hist Sci Med. 37 (4): 463β9. PMIDΒ 14989211.
- β Mazana J, AriΓ±o MR (1991). “Charles Robert Richet and some milestones in the history of allergies”. J Investig Allergol Clin Immunol. 1 (2): 93β100. PMIDΒ 1669573.
- β LoVerde D, Iweala OI, Eginli A, Krishnaswamy G (2018). “Anaphylaxis”. Chest. 153 (2): 528β543. doi:10.1016/j.chest.2017.07.033. PMCΒ 6026262. PMIDΒ 28800865.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Dushka Riaz, MD
